Vol 12, No 3 (June 30, 2023): Chinese Clinical Oncology

Original Article

Comparison of PARPi efficacy according to homologous recombination deficiency biomarkers in patients with ovarian cancer: a systematic review and meta-analysis
Felipe Batalini, Laercio Lopes DaSilva, Leticia Campoverde, Ana Carolina Marin Comini, Bruno Murad Carvalho, Wilson Nogueira, Hyan Silveira, Brenda J. Ernst, Lida A. Mina
Lymph node staging with 68Ga-PSMA PET in patients with intermediate and high-risk prostate cancer suitable for radical prostatectomy managed in a prostate cancer unit
Umberto Vittorio Maestroni, Davide Campobasso, Giulio Guarino, Anna Acampora, Maura Scarlattei, Francesco Ziglioli, Francesco Dinale, Giorgio Baldari, Silvia Migliari, Donatello Gasparro, Stefania Ferretti, Enrico Maria Silini, Livia Ruffini
Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial
Louis Cappelli, Mehak Majid Khan, Allison Kayne, Spencer Poiset, Ryan Miller, Ayesha Ali, Muneeb Niazi, Wenyin Shi, Iyad Alnahhas